[122]
Apotex' expert, Dr. Mislow, testified on cross-examination that the enantiomers of ofloxacin are distinct from racemic ofloxacin. This is consistent with the Federal Court of Appeal's finding in the
Novopharm
Appeal: "Each of the two enantiomers of a racemate is a different compound than the racemate, and may have different properties, including different medicinal properties." (Mislow Cross, q. 69, AR, v. 48, Tab 79, p. 15842;
Novopharm
Appeal, above at para. 12.)